TickerFacts.

A business in context

CTNM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-14 · 0001628280-26-061834 · Items 8.01,9.01

  2. 4 · Ownership change

    Report date 2026-09-08 · 0001628280-26-060962

  3. 4 · Ownership change

    Report date 2026-08-03 · 0001628280-26-052031

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-051054

  5. 8-K · Current report

    Report date 2026-07-30 · 0001628280-26-051051 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-13 · 0001628280-26-048023 · Items 7.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-08 · 0001628280-26-047909

  8. 4 · Ownership change

    Report date 2026-07-08 · 0001628280-26-047710

  9. 4 · Ownership change

    Report date 2026-06-30 · 0001628280-26-047058

  10. 4 · Ownership change

    Report date 2026-06-30 · 0001628280-26-046654

  11. 4 · Ownership change

    Report date 2026-06-30 · 0001628280-26-046653

  12. 4 · Ownership change

    Report date 2026-06-26 · 0001628280-26-045845

  13. 8-K · Current report

    Report date 2026-06-26 · 0001628280-26-045804 · Items 5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-030614

  15. 8-K · Current report

    Report date 2026-05-05 · 0001628280-26-030522 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-26 · 0001628280-26-028881

  17. 8-K · Current report

    Report date 2026-04-30 · 0001628280-26-028876 · Items 7.01,8.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-015165

  19. 8-K · Current report

    Report date 2026-03-05 · 0001628280-26-015159 · Items 2.02,8.01,9.01

  20. 8-K · Current report

    Report date 2026-01-23 · 0001437749-26-002072 · Items 5.02,9.01

  21. 8-K · Current report

    Report date 2025-12-11 · 0001437749-25-037842 · Items 1.01,8.01,9.01

  22. 8-K · Current report

    Report date 2025-12-08 · 0001437749-25-037547 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-11-20 · 0001437749-25-035860 · Items 8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-032427

  25. 8-K · Current report

    Report date 2025-10-30 · 0001437749-25-032422 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-09-18 · 0001437749-25-029349 · Items 7.01,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-024852

  28. 8-K · Current report

    Report date 2025-08-05 · 0001437749-25-024849 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-26 · 0001437749-25-021343 · Items 5.07

  30. 8-K · Current report

    Report date 2025-05-14 · 0001437749-25-016877 · Items 2.02,8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-016835

  32. DEF 14A · Proxy statement

    Report date 2025-06-26 · 0001437749-25-013528

  33. 8-K · Current report

    Report date 2025-04-28 · 0001437749-25-013334 · Items 8.01,9.01

  34. 8-K · Current report

    Report date 2025-03-14 · 0001437749-25-007998 · Items 5.02,9.01

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-006458

  36. 8-K · Current report

    Report date 2025-03-06 · 0001437749-25-006457 · Items 2.02,9.01

  37. SC 13G · Ownership disclosure

    0001104659-24-119059

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-033616

  39. 8-K · Current report

    Report date 2024-11-06 · 0001437749-24-033614 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-026680

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 10 transaction rows10SGrant / award: 0 transaction rows0AExercise / conversion: 20 transaction rows20MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

30 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-08
Stengone Carmine N.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2500.016.46
2026-09-08
2026-09-08
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock2500.01.01
2026-09-08
2026-09-08
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
2500.00.0
2026-08-03
2026-08-03
Stengone Carmine N.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2500.016.01
2026-08-03
2026-08-03
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock2500.01.01
2026-08-03
2026-08-03
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
2500.00.0
2026-07-09
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock25.016.0
2026-07-09
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock25.01.01
2026-07-09
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
25.00.0
2026-07-08
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock1015.01.01
2026-07-08
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock1015.016.0
2026-07-08
2026-07-10
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
1015.00.0
2026-07-08
2026-07-08
Stengone Carmine N.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2500.016.0
2026-07-08
2026-07-08
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock2500.01.01
2026-07-08
2026-07-08
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
2500.00.0
2026-07-01
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock2501.016.24
2026-07-01
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock5852.015.67
2026-07-01
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock4183.01.01
2026-07-01
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
4183.00.0
2026-06-30
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock28826.016.04
2026-06-30
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock28826.01.01
2026-06-30
2026-07-02
Lorrain Daniel S.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
28826.00.0
2026-06-30
2026-07-01
Watkins Tim
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock10833.04.5
2026-06-30
2026-07-01
Watkins Tim
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock10833.016.02
2026-06-30
2026-07-01
Watkins Tim
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
10833.00.0
2026-06-30
2026-07-01
Stengone Carmine N.
10b5-1 checkbox reported
S · Sale
Disposed
Class A Common Stock10000.016.01
2026-06-30
2026-07-01
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock7500.01.01
2026-06-30
2026-07-01
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Class A Common Stock2500.01.26
2026-06-30
2026-07-01
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
2500.00.0
2026-06-30
2026-07-01
Stengone Carmine N.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
7500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001855175Contineum Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0
    2023-12-31$50.00M$55.29M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗